All In Biotech

Free tool

FAERS Monitor: Foundayo

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 220934 or its brand name (Foundayo, Orforglipron Calcium). Reports on generic versions are filed under their own applications.

Reports

3,056

Serious

138

5% of reports

Hospitalization

58

Death reported

4

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea717
  • drug ineffective551
  • constipation331
  • vomiting282
  • weight increased246
  • fatigue227
  • weight loss poor218
  • diarrhoea212
  • headache187
  • illness147
  • abdominal pain upper137
  • dizziness130
  • dyspepsia115
  • abdominal discomfort110
  • abdominal distension99

Reports by year received

View as table
YearReports
20251
20263,055

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,103 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
weight loss poorSignal218306.5268.863,270
constipationSignal33110.59.42,848
illnessSignal1479.88.41,162
dyspepsiaSignal1158.16.7706
weight increasedSignal2467.66.71,409
abdominal distensionSignal996.55.4460
nauseaSignal7176.25.93,270
abdominal pain upperSignal1374.63.9384
abdominal discomfortSignal1104.53.8300
vomitingSignal2824.13.7681
drug ineffectiveSignal5512.92.7718
diarrhoeaSignal2122.32.0152
headacheSignal1872.11.8103
fatigueSignal2272.01.8118
dizziness1301.81.546

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.